Key Financial Data Of Group

STELLA PHARMA CORPORATION - Filing #7299803

Concept 2024-04-01 to
2024-09-30
As at
2024-09-30
As at
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2023-09-30
As at
2023-09-30
Key financial data of group
Business results of group
Net sales
169,394,000 JPY
269,491,000 JPY
153,995,000 JPY
Ordinary profit (loss)
-267,279,000 JPY
-760,208,000 JPY
-303,679,000 JPY
Net assets
3,079,576,000 JPY
2,377,012,000 JPY
2,834,904,000 JPY
Total assets
5,205,185,000 JPY
3,820,622,000 JPY
4,141,782,000 JPY
Basic earnings (loss) per share
-8.21
-24.66
-9.95
Diluted earnings per share
Equity-to-asset ratio
0.5916 xbrli:pure
0.6203 xbrli:pure
0.6828 xbrli:pure
Net cash provided by (used in) operating activities
545,793,000 JPY
-876,837,000 JPY
-435,804,000 JPY
Net cash provided by (used in) investing activities
88,185,000 JPY
-9,010,000 JPY
-10,578,000 JPY
Net cash provided by (used in) financing activities
865,559,000 JPY
228,353,000 JPY
308,339,000 JPY
Cash and cash equivalents
3,511,772,000 JPY
2,012,233,000 JPY
2,531,683,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.